These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 4271903)
1. Number of ouabain-binding sites in fibroblasts from normal subjects and patients with cystic fibrosis. Quissell DO; Pitot HC Nature; 1974 Jan; 247(5436):115-6. PubMed ID: 4271903 [No Abstract] [Full Text] [Related]
3. Incorporation of L-leucine and D-glucosamine into skin fibroblasts derived from cystic fibrosis and normal individuals. Fletcher DS; Tsau-Yen-Lin Clin Chim Acta; 1973 Feb; 44(1):5-19. PubMed ID: 4267644 [No Abstract] [Full Text] [Related]
4. Na and K dependence of the Na/K pump in cystic fibrosis fibroblasts. Reznik VM; Schneider JA; Mendoza SA Proc Natl Acad Sci U S A; 1981 Nov; 78(11):7143-6. PubMed ID: 6947278 [TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis: effect of media from cultured cystic fibrosis fibroblasts on ATPase activity. Schmoyer IR; Baglia FA Biochem Biophys Res Commun; 1974 Jun; 58(4):1066-70. PubMed ID: 4275864 [No Abstract] [Full Text] [Related]
7. The role of phospholipids in the binding of ouabain to sodium- and potassium-dependent adenosine triphosphatase. Taniguchi K; Iida S Mol Pharmacol; 1973 May; 9(3):350-9. PubMed ID: 4267958 [No Abstract] [Full Text] [Related]
8. Ouabain binding to the sodium pump. Chipperfield AR; Whittam R Nature; 1973 Mar; 242(5392):62-3. PubMed ID: 4266529 [No Abstract] [Full Text] [Related]
9. The binding of tritiated ouabain to sodium- and potassium-activated adenosine triphosphatase and cardiac relaxing system of perfused dog heart. Allen JC; Besch HR; Glick G; Schwartz A Mol Pharmacol; 1970 Jul; 6(4):441-3. PubMed ID: 4246826 [No Abstract] [Full Text] [Related]
10. Ouabain binding to sodium- and potassium-dependent adenosine triphosphatase: inhibition by the , -methylene analogue of adenosine triphosphate. Tobin T; Akera T; Hogg RE; Brody TM Mol Pharmacol; 1973 Mar; 9(2):278-81. PubMed ID: 4268124 [No Abstract] [Full Text] [Related]
11. Erythrocyte transport function in cystic fibrosis. Feig SA; Segel GB; Kern KA; Osher AB; Schwartz RH Pediatr Res; 1974 May; 8(5):594-7. PubMed ID: 4274932 [No Abstract] [Full Text] [Related]
12. Calcium and sodium transport processes in patients with cystic fibrosis 2. Mg2+- dependent, Ca2+ ATPase activity in fibroblast membrane preparations from cystic fibrosis patients and controls. Katz S Res Commun Chem Pathol Pharmacol; 1978 Mar; 19(3):491-503. PubMed ID: 148720 [TBL] [Abstract][Full Text] [Related]
13. Effect of phospholipase A treatment on the partial reactions of and ouabain binding to a purified sodium and potassium activated adenosine triphosphatase. Lane LK; Anner BM; Wallick ET; Ray MV; Schwartz A Biochem Pharmacol; 1978 Jan; 27(2):225-31. PubMed ID: 146495 [No Abstract] [Full Text] [Related]
14. Na-K pump site density and ouabain binding affinity in cultured chick heart cells. Lobaugh LA; Lieberman M Am J Physiol; 1987 Nov; 253(5 Pt 1):C731-43. PubMed ID: 2446503 [TBL] [Abstract][Full Text] [Related]
15. Changes in erythrocyte membrane ATPase in patients with cystic fibrosis of the pancreas. Cole CH; Dirks JH Pediatr Res; 1972 Jul; 6(7):616-21. PubMed ID: 4262554 [No Abstract] [Full Text] [Related]
16. Suramin: a potent ATPase inhibitor which acts on the inside surface of the sodium pump. Fortes PA; Ellory JC; Lew VL Biochim Biophys Acta; 1973 Aug; 318(2):262-72. PubMed ID: 4355468 [No Abstract] [Full Text] [Related]
17. Distinguishing homozygous and heterozygous cystic fibrosis fibroblasts from normal cells by differences in sodium transport. Breslow JL; McPherson J; Epstein J N Engl J Med; 1981 Jan; 304(1):1-5. PubMed ID: 7432432 [TBL] [Abstract][Full Text] [Related]
19. Na+/K+ ATPase in lower airway epithelium from cystic fibrosis and non-cystic-fibrosis lung. Peckham D; Holland E; Range S; Knox AJ Biochem Biophys Res Commun; 1997 Mar; 232(2):464-8. PubMed ID: 9125202 [TBL] [Abstract][Full Text] [Related]